Arneric (29 résultats)

Hardcover. Etat : Very Good. xii 421p large hardback, a new copy never used Language: English.

Hardcover. Etat : New. 1st Edition.

Couverture souple. Etat : bon. R100000068: Non daté. In-12. Broché. Bon état, Couv. convenable, Dos satisfaisant, Intérieur frais. Affiche de cinéma 120 cm x160 cm. Présenté par Paul de Roubaix. . . . Classification : 0-Affiches Cinéma.

hardcover. Etat : New. In shrink wrap. Looks like an interesting title.

Etat : New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Etat : Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Etat : Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Etat : Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Etat : Used. pp. xii + 421 1st Edition.

Etat : Used. pp. xii + 421 Illus.

Etat : Used. pp. xii + 421.

Etat : As New. Unread book in perfect condition.

Etat : new.

Etat : New.

Etat : New. In English.

Etat : New.

Etat : As New. Unread book in perfect condition.

Hardback. Etat : New. 1st. Neuronal Nicotinic Receptors: Pharmacology and TherapeuticOpportunities Edited by Stephen P. Arneric and Jorge D. Brioni Nicotine's efficacy in the treatment of pain and anxiolysis, andits usefulness as a memory enhancer, have been suspected for manyyears, but research into the molecular biology of nicotinicacetylcholine receptors (nAChRs) traditionally has focused onsmoking cessation. Now, thanks to recent technological advances inthe molecular biology and electrophysiology of nAChRs, an abundanceof evidence has emerged in support of nAChR ligands in thetreatment of a range of CNS disorders, including Alzheimer'sdisease, Parkinson's disease, neuropathic pain, attention deficitdisorder, and depression. Featuring contributions from an international team of experts inthe field, this volume provides researchers and clinicians with acomprehensive review of nAChRs, their molecular biology,pharmacology, and clinical implications. Moving from the molecularto the clinical levels, the authors explore the latest developmentsin all areas of nAChR research, including: * Molecular biology and biochemistry of nAChRs * The physiological roles of nAChRs * Pharmacokinetics of nicotine-like alkaloids * Recent breakthroughs and emerging trends in nAChR medicinalchemistry * Current and emerging therapeutic applications of novel nAChRligands. A timely, authoritative review of basic research into nAChRs andtheir role in the development of new therapeutic strategies in thetreatment of a range of various CNS diseases, Neuronal NicotinicReceptors: Pharmacology and Therapeutic Opportunities is requiredreading for neuroscientists, pharmacologists, medicinal chemists,biological psychiatrists, and psychopharmacologists.…

Etat : New.

Hardcover. Etat : Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Etat : New. This text ties together basic research to the discovery of modern agents, and provides therapeutic strategies for the treatment of certain disorders of the central nervous system. It includes a comprehensive review of nicotinic receptors, from the molecular.

Hardback. Etat : New. 1st. Neuronal Nicotinic Receptors: Pharmacology and TherapeuticOpportunities Edited by Stephen P. Arneric and Jorge D. Brioni Nicotine's efficacy in the treatment of pain and anxiolysis, andits usefulness as a memory enhancer, have been suspected for manyyears, but research into the molecular biology of nicotinicacetylcholine receptors (nAChRs) traditionally has focused onsmoking cessation. Now, thanks to recent technological advances inthe molecular biology and electrophysiology of nAChRs, an abundanceof evidence has emerged in support of nAChR ligands in thetreatment of a range of CNS disorders, including Alzheimer'sdisease, Parkinson's disease, neuropathic pain, attention deficitdisorder, and depression. Featuring contributions from an international team of experts inthe field, this volume provides researchers and clinicians with acomprehensive review of nAChRs, their molecular biology,pharmacology, and clinical implications. Moving from the molecularto the clinical levels, the authors explore the latest developmentsin all areas of nAChR research, including: * Molecular biology and biochemistry of nAChRs * The physiological roles of nAChRs * Pharmacokinetics of nicotine-like alkaloids * Recent breakthroughs and emerging trends in nAChR medicinalchemistry * Current and emerging therapeutic applications of novel nAChRligands. A timely, authoritative review of basic research into nAChRs andtheir role in the development of new therapeutic strategies in thetreatment of a range of various CNS diseases, Neuronal NicotinicReceptors: Pharmacology and Therapeutic Opportunities is requiredreading for neuroscientists, pharmacologists, medicinal chemists,biological psychiatrists, and psychopharmacologists.…

Etat : New. This text ties together basic research to the discovery of modern agents, and provides therapeutic strategies for the treatment of certain disorders of the central nervous system. It includes a comprehensive review of nicotinic receptors, from the molecular level to clinical applications. Editor(s): Arneric, Stephen P.; Brioni, Jorge D. Num Pages: 422 pages, Illustrations. BIC Classification: MFC; MJN; MMZ; PSD. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 237 x 180 x 30. Weight in Grams: 752. . 1999. 1st Edition. Hardcover. . . . .…

Hardcover. Etat : Brand New. 421 pages. 9.50x6.50x1.00 inches. In Stock.

Buch. Etat : Neu. Neuware - Neuronal Nicotinic Receptors: Pharmacology and TherapeuticOpportunities Edited by Stephen P. Arneric and Jorge D. Brioni Nicotine's efficacy in the treatment of pain and anxiolysis, andits usefulness as a memory enhancer, have been suspected for manyyears, but research into the molecular biology of nicotinicacetylcholine receptors (nAChRs) traditionally has focused onsmoking cessation. Now, thanks to recent technological advances inthe molecular biology and electrophysiology of nAChRs, an abundanceof evidence has emerged in support of nAChR ligands in thetreatment of a range of CNS disorders, including Alzheimer'sdisease, Parkinson's disease, neuropathic pain, attention deficitdisorder, and depression. Featuring contributions from an international team of experts inthe field, this volume provides researchers and clinicians with acomprehensive review of nAChRs, their molecular biology,pharmacology, and clinical implications. Moving from the molecularto the clinical levels, the authors explore the latest developmentsin all areas of nAChR research, including: \* Molecular biology and biochemistry of nAChRs \* The physiological roles of nAChRs \* Pharmacokinetics of nicotine-like alkaloids \* Recent breakthroughs and emerging trends in nAChR medicinalchemistry \* Current and emerging therapeutic applications of novel nAChRligands. A timely, authoritative review of basic research into nAChRs andtheir role in the development of new therapeutic strategies in thetreatment of a range of various CNS diseases, Neuronal NicotinicReceptors: Pharmacology and Therapeutic Opportunities is requiredreading for neuroscientists, pharmacologists, medicinal chemists,biological psychiatrists, and psychopharmacologists.…

Etat : New. This text ties together basic research to the discovery of modern agents, and provides therapeutic strategies for the treatment of certain disorders of the central nervous system. It includes a comprehensive review of nicotinic receptors, from the molecular level to clinical applications. Editor(s): Arneric, Stephen P.; Brioni, Jorge D. Num Pages: 422 pages, Illustrations. BIC Classification: MFC; MJN; MMZ; PSD. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 237 x 180 x 30. Weight in Grams: 752. . 1999. 1st Edition. Hardcover. . . . . Books ship from the US and Ireland.…

Couverture souple. Etat : bon. R100000069: Non daté. In-12. Broché. Bon état, Couv. convenable, Dos satisfaisant, Intérieur frais. Affiche de cinéma 120 cm x160 cm + 12 photos de présentation de 27 x 21 cm (série A et série B). + 1 affiche recto verso avec le résumé. Présenté par Paul de Roubaix. . . . Classification : 0-Affiches Cinéma. …

Hardcover. Etat : new. Hardcover. Neuronal Nicotinic Receptors: Pharmacology and TherapeuticOpportunities Edited by Stephen P. Arneric and Jorge D. Brioni Nicotine's efficacy in the treatment of pain and anxiolysis, andits usefulness as a memory enhancer, have been suspected for manyyears, but research into the molecular biology of nicotinicacetylcholine receptors (nAChRs) traditionally has focused onsmoking cessation. Now, thanks to recent technological advances inthe molecular biology and electrophysiology of nAChRs, an abundanceof evidence has emerged in support of nAChR ligands in thetreatment of a range of CNS disorders, including Alzheimer'sdisease, Parkinson's disease, neuropathic pain, attention deficitdisorder, and depression. Featuring contributions from an international team of experts inthe field, this volume provides researchers and clinicians with acomprehensive review of nAChRs, their molecular biology,pharmacology, and clinical implications. Moving from the molecularto the clinical levels, the authors explore the latest developmentsin all areas of nAChR research, including: * Molecular biology and biochemistry of nAChRs * The physiological roles of nAChRs * Pharmacokinetics of nicotine-like alkaloids * Recent breakthroughs and emerging trends in nAChR medicinalchemistry * Current and emerging therapeutic applications of novel nAChRligands. A timely, authoritative review of basic research into nAChRs andtheir role in the development of new therapeutic strategies in thetreatment of a range of various CNS diseases, Neuronal NicotinicReceptors: Pharmacology and Therapeutic Opportunities is requiredreading for neuroscientists, pharmacologists, medicinal chemists,biological psychiatrists, and psychopharmacologists. This text ties together basic research to the discovery of modern agents, and provides therapeutic strategies for the treatment of certain disorders of the central nervous system. It includes a comprehensive review of nicotinic receptors, from the molecular level to clinical applications. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…

Hardcover. Etat : Brand New. 421 pages. 9.50x6.50x1.00 inches. In Stock. This item is printed on demand.